Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $10.92 $17.05 Thursday, 9th May 2024 SAGE stock ended at $12.34. This is 0.404% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.87% from a day low at $12.20 to a day high of $12.55.
90 days $10.92 $27.39
52 weeks $10.92 $59.98

Historical Sage Therapeutics prices

Date Open High Low Close Volume
Oct 04, 2023 $20.01 $20.01 $19.47 $19.67 1 678 186
Oct 03, 2023 $19.71 $20.13 $19.47 $20.08 763 229
Oct 02, 2023 $20.59 $20.62 $19.70 $19.76 972 118
Sep 29, 2023 $20.92 $20.98 $20.30 $20.58 759 741
Sep 28, 2023 $21.03 $21.55 $20.23 $20.72 1 070 423
Sep 27, 2023 $20.77 $21.35 $20.62 $21.31 1 093 731
Sep 26, 2023 $19.36 $20.98 $19.21 $20.84 1 285 807
Sep 25, 2023 $19.48 $19.58 $19.20 $19.26 1 137 970
Sep 22, 2023 $19.63 $20.00 $19.37 $19.56 866 510
Sep 21, 2023 $19.87 $19.87 $19.28 $19.60 1 053 204
Sep 20, 2023 $20.45 $20.65 $19.86 $19.90 1 260 210
Sep 19, 2023 $20.48 $20.67 $20.03 $20.45 1 162 144
Sep 18, 2023 $21.03 $21.03 $19.99 $20.30 1 946 262
Sep 15, 2023 $21.59 $21.75 $20.53 $21.02 5 101 870
Sep 14, 2023 $22.80 $23.18 $21.21 $21.49 2 380 532
Sep 13, 2023 $23.69 $23.96 $22.50 $22.66 1 996 408
Sep 12, 2023 $21.57 $23.58 $21.53 $23.44 1 707 404
Sep 11, 2023 $21.65 $22.24 $21.46 $21.65 1 190 871
Sep 08, 2023 $20.97 $21.82 $20.56 $21.61 1 339 777
Sep 07, 2023 $20.52 $21.10 $20.22 $20.89 1 045 661
Sep 06, 2023 $20.62 $20.95 $20.38 $20.64 870 702
Sep 05, 2023 $20.15 $20.66 $19.75 $20.57 1 493 677
Sep 01, 2023 $20.22 $20.66 $20.10 $20.29 1 213 052
Aug 31, 2023 $19.67 $20.45 $19.67 $20.00 1 233 467
Aug 30, 2023 $19.96 $20.19 $19.49 $19.72 912 011
Click to get the best stock tips daily for free!

About Sage Therapeutics

Sage Therapeutics Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment... SAGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT